Back to Newsroom
Back to Newsroom

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLI, RDW and TLIS

Wednesday, 26 January 2022 07:00 PM

The Gross Law Firm

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / January 26, 2022 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Berkeley Lights, Inc. (NASDAQ:BLI)
Investors Affected: July 17, 2020 - September 14, 2021
A class action has commenced on behalf of certain shareholders in Berkeley Lights, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Berkeley Lights' flagship instrument, the Beacon, suffered from numerous design and manufacturing defects including breakdowns, high error rates, data integrity issues and other problems, limiting the ability of biotechnology companies and research institutions to consistently use the machines at scale; (b) Berkeley Lights had received numerous customer complaints regarding the durability and effectiveness of the Company's automation systems; (c) the actual market for Berkeley Lights' products and services was a fraction of the $23 billion represented to investors because of, inter alia, the relatively high cost of the Company's instruments and consumables and inability to provide the sustained performance necessary to justify these high costs; and (d) as a result of (a)-(c), above, defendants' statements to investors during the Class Period regarding Berkeley Lights' business, operations and financial results were materially false and misleading.

Shareholders may find more information at https://securitiesclasslaw.com/securities/berkeley-lights-inc-loss-submission-form/?id=22592&from=1

Redwire Corporation f/k/a/ Genesis Park Acquisition Corp (NYSE:RDW)
Investors Affected: August 11, 2021 - November 14, 2021
A class action has commenced on behalf of certain shareholders in Redwire Corporation f/k/a/ Genesis Park Acquisition Corp. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) there were accounting issues at one of Redwire's subunits; (2) as a result, there were additional material weaknesses in Redwire's internal control over financial reporting; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/redwire-corporation-f-k-a-genesis-park-acquisition-corp-loss-submission-form/?id=22592&from=1

Talis Biomedical Corporation (NASDAQ:TLIS)
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Talis common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's February 2021 initial public offering.
A class action has commenced on behalf of certain shareholders in Talis Biomedical Corporation. According to the lawsuit, documents that the Company issued in connection with its IPO failed to disclose to investors: (1) that the comparator assay in the primary study lacked sufficient sensitivity to support Talis's Emergency Use Authorization application for Talis One COVID-19 test; (2) that, as a result, Talis was reasonably likely to experience delays in obtaining regulatory approval for the Talis One COVID-19 test; (3) that, as a result, the Company's commercialization timeline would be significantly delayed; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/talis-biomedical-corporation-loss-submission-form/?id=22592&from=1

The Gross Law Firm, Wednesday, January 26, 2022, Press release picture

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: